Primary Immunodeficiencies Associated with EBV Disease
- PMID: 26424649
- PMCID: PMC6349415
- DOI: 10.1007/978-3-319-22822-8_10
Primary Immunodeficiencies Associated with EBV Disease
Abstract
Epstein-Barr virus (EBV) infects nearly all humans and usually is asymptomatic, or in the case of adolescents and young adults, it can result in infectious mononucleosis. EBV-infected B cells are controlled primarily by NK cells, iNKT cells, CD4 T cells, and CD8 T cells. While mutations in proteins important for B cell function can affect EBV infection of these cells, these mutations do not result in severe EBV infection. Some genetic disorders affecting T and NK cell function result in failure to control EBV infection, but do not result in increased susceptibility to other virus infections. These include mutations in SH2D1A, BIRC4, ITK, CD27, MAGT1, CORO1A, and LRBA. Since EBV is the only virus that induces proliferation of B cells, the study of these diseases has helped to identify proteins critical for interactions of T and/or NK cells with B cells. Mutations in three genes associated with hemophagocytic lymphohistocytosis, PRF1, STXBP2, and UNC13D, can also predispose to severe chronic active EBV disease. Severe EBV infection can be associated with immunodeficiencies that also predispose to other viral infections and in some cases other bacterial and fungal infections. These include diseases due to mutations in PIK3CD, PIK3R1, CTPS1, STK4, GATA2, MCM4, FCGR3A, CARD11, ATM, and WAS. In addition, patients with severe combined immunodeficiency, which can be due to mutations in a number of different genes, are at high risk for various infections as well as EBV B cell lymphomas. Identification of proteins important for control of EBV may help to identify new targets for immunosuppressive therapies.
Similar articles
-
When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.Clin Microbiol Infect. 2023 Apr;29(4):457-462. doi: 10.1016/j.cmi.2022.10.003. Epub 2022 Oct 6. Clin Microbiol Infect. 2023. PMID: 36209991 Free PMC article. Review.
-
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.Immunol Rev. 2019 Sep;291(1):174-189. doi: 10.1111/imr.12791. Immunol Rev. 2019. PMID: 31402499 Review.
-
Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.Front Immunol. 2018 Jun 4;9:1103. doi: 10.3389/fimmu.2018.01103. eCollection 2018. Front Immunol. 2018. PMID: 29942301 Free PMC article. Review.
-
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.J Allergy Clin Immunol. 2019 Jan;143(1):276-291.e6. doi: 10.1016/j.jaci.2018.04.030. Epub 2018 May 22. J Allergy Clin Immunol. 2019. PMID: 29800648
-
Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.Clin Infect Dis. 2016 Jul 1;63(1):41-7. doi: 10.1093/cid/ciw160. Epub 2016 May 11. Clin Infect Dis. 2016. PMID: 27169477 Free PMC article.
Cited by
-
Acalculous Cholecystitis as a Complication of Primary Epstein-Barr Virus Infection: A Case-Based Scoping Review of the Literature.Viruses. 2024 Mar 18;16(3):463. doi: 10.3390/v16030463. Viruses. 2024. PMID: 38543828 Free PMC article. Review.
-
A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry.Ann Med. 2024 Dec;56(1):2329136. doi: 10.1080/07853890.2024.2329136. Epub 2024 Mar 19. Ann Med. 2024. PMID: 38502913 Free PMC article. Review.
-
Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells.Immunity. 2024 Mar 12;57(3):559-573.e6. doi: 10.1016/j.immuni.2024.02.008. Immunity. 2024. PMID: 38479361
-
Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers.Cancers (Basel). 2024 Feb 29;16(5):991. doi: 10.3390/cancers16050991. Cancers (Basel). 2024. PMID: 38473352 Free PMC article. Review.
-
Changes in Spectrum of Respiratory Pathogen Infections and Disease Severity Among Children in Hohhot, China: Impact of COVID-19 Prevention Measures.Med Sci Monit. 2024 Mar 7;30:e942845. doi: 10.12659/MSM.942845. Med Sci Monit. 2024. PMID: 38451880 Free PMC article.
References
-
- Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, Raddaoui E, Almomen AK, Al-Muhsen S, Geha RS, Alkuraya FS. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 2012. August;130(2):481–8. - PMC - PubMed
-
- Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markelj G, Chandra A, Farmer G, Kielkowska A, Clark J, Kracker S, Debré M, Picard C, Pellier I, Jabado N, Morris JA, Barcenas-Morales G, Fischer A, Stephens L, Hawkins P, Barrett JC, Abinun M, Clatworthy M, Durandy A, Doffinger R, Chilvers ER, Cant AJ, Kumararatne D, Okkenhaug K, Williams RL, Condliffe A, Nejentsev S. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 2013. November 15;342(6160):866–71. - PMC - PubMed
-
- Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, Heath PT, Steward CG, Smith O, O’Meara A, Kerrigan H, Mahlaoui N, Cavazzana-Calvo M, Fischer A, Moshous D, Blanche S, Pachlopnik Schmid J, Latour S, de Saint-Basile G, Albert M, Notheis G, Rieber N, Strahm B, Ritterbusch H, Lankester A, Hartwig NG, Meyts I, Plebani A, Soresina A, Finocchi A, Pignata C, Cirillo E, Bonanomi S, Peters C, Kalwak K, Pasic S, Sedlacek P, Jazbec J, Kanegane H, Nichols KE, Hanson IC, Kapoor N, Haddad E, Cowan M, Choo S, Smart J, Arkwright PD, Gaspar HB. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011. January 6;117(1):53–62. - PMC - PubMed
-
- Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, Landi E, Biassoni R, Notarangelo LD, Moretta L, Moretta A. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 2001. August 6;194(3):235–46. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous